AllPennyStocks.com News: Junior Pharma Company Picks Up Antibody Platform From Major (QPT.V)

MISSISSAUGA, Ontario, October 1, 2009 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Junior Pharma Company Picks Up Antibody Platform From Major."

Companies mentioned in this article include Quest PharmaTech Inc. (TSX-Venture:QPT) and Paladin Labs Inc. (TSX:PLB).

Article Excerpt:

In the world of pharmaceuticals, new developments are making their presence felt all the time. Sometimes those news items involve a larger company joining forces with smaller ones to create synthesis and greater efficiencies, as the firms gain more strength to get their products to the patent office, and from there, to market.

The last day of September, and of the last quarter, proved significant in the commercial drug game for Edmonton-based Quest PharmaTech Inc. (TSX-Venture:QPT), a key player in the fight against cancers and dermatological ailments. For it was on that day that QPT bought a portfolio of immunotherapeutic antibodies as well as related intellectual property and other assets from Montreal-based Paladin Labs Inc. (TSX:PLB), in exchange for five million Quest PharmaTech shares, royalties on future revenues and cash.

PLB, meantime, will continue to develop its Chimigen(R) Platform Technology to fight Hepatitis B, Hepatitis C and other diseases.

The full version of this article can be found at:

http://www.allpennystocks.com/aps_ca/special_reports/064/Junior-Pharma-Company-Picks-Up-Antibody-Platform-From-Major.htm

About AllPennyStocks.com:

AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs weekly stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.

AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.

Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.

Contact:

AllPennyStocks.com Media, Inc.

Peter Szafranski -- President

Phone: (905) 361-5680

E-Mail: peter@allpennystocks.com

Note: AllPennyStocks.com has not received compensation for carrying the other above-mentioned companies; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.

Related terms: business, canada, cancer, community, corporate, edmonton, email, e-mail, investment opinion, market, media, montreal, note, ontario, otc, pharmaceuticals, president, products, property, subscription, technology